Philip Morris
Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
Fields
- Author
- Russell, Mah
- Sutton, S.R.
- Vesey, C.J.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Bat, British American Tobacco
- Medical Research Council
- Named Person
- Amato, V.
- Saloojee, Y.
- Taylor, C.
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Author (Organization)
- British Journal of Addiction
- Inst of Psychiatry
- New Cross Hospital
- St Bartholomews Hospital
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
1
I
eruuA fwn..l.f Al1ua.. 77 (1982) 1145-158
© 1982 Society for the study of Addiction m Alwhol and other Dru;s.
0007 4A90/d2/QO 19-0145 f02.00
Long-Term Switching to Loyv-Tar Low-Nicoti.ne
Cigarettes
M. A. H. Russell, F.R.C.P., F.R.C.Psych, Senior L.ecturer, S. R. Sutton,
Ph.D., Psychologist, R. Iyer, Statistical Assistant, C. Feyerabend BSc., Senior
Biochemist', C. J. Vesey M.Sc., M.L BioL, Research Assistaat'
Addutioa Rssearc/t Uuit, lustitute of Psycliiatry, Losdos SES 8AF
Summary
Pxjfis j,%tsers.ad bl.od>wasrra.f ssob istarte tnore stsdied is 1Y serbj+cts kf.n sd.f ter smitcA=q
&loan-ta (10.9 xj) lom-sicotise (0.7stj) cilaettes f.r 12 sve+ats. Puff rste, /WffaeGose, totd
aolsaru
Nffed jer erj jaette iad tlae sssikr of ci jntttes ssubed mm sN ui.ued si,pajitsstlj 4fter smitc*j
to
t+4 loawyield cqaettes. T<ae ndreti.. iie srfttA-lsarl rsiatiae iataEe (eslcrlaed fi..e brtt
cattest) was
Nkxtical So tla 47 jer cest eedsctioa is the wschiar-ssaked sisetiaerXds. Ms ic in teejest ivith the
sstmtrsu of ~/'ssj is shmW tir .bseacs of sy asdeacj a nVeles.k for the rrdwad yirllr h
wcntsis; dr iRte" of Pwffiq. Ir: caitrast, plasrna aicotiuu aad c.titeixe /eaels asre redrud
proportiosally kss tkox the soaemal yieldr isdicstis( that Ae srbjects cowepeisseted to sm eztest by
wreasit;l neltalttiois. Tlic saersje rtttrctinet ia jlstws rticotis~r ad caisise Were idestiesl
(Japa aat).
Plasnsa tkiocya.ate sid CONb leatls mere sot sipifuastly deretit sftsr smitckiu to the loanerpield
ei jaeettu but the estiuRalsd tas' iatahc to the lwc js &W reduced bJ about 13 jer ctst. A1tbsqi *
/wcyield
aidvettes run r.ted as slqArtly 1ae sAeit, Ae+r aw rse sipafueat lss .f otti.tf.cti.s. T4 fict tAst
arif etsr s.lerated a J19 per cent nd.ctis a #ans sicsti.r roithst ltfst of sairf.cti...nd eoitiwt
pq(fnq awr aasessisey s>ICUests tbt the isrnesss ia i.i.lstm aw sot &amad y t ssed ta arataie
4rieatisr rstab. ; This ssd the discrepauies ktmetu aatrssl s.d erperixtental smitcllistg shrdies ae
discrssed.
Iatroduction
It is widely believed that a change to low-tar and low-nicotine cigarettes reduces the
health hazards of cigarette smoking. It is not known, however, to what extent the
benefits ofsuch a change are offset by the tendency for smokers to compensate for the
reduction in tar and nicotine yields by smoking more cigarettes or by increasing the
intensity of puffing and inhalation. At present the evidence is somewhat conflicting
[l-3).
Two different approaches have been used to study this question. One approach
has been to compare blood nicotine and carboxyhaemoglobin (COHb) levels of
smokers who regularly smoke low-tar low-nicotine cigarettes with the levels of those
who smoke brands with higher yields. Two such studies using large samples have
found very little diBerence in the blood nicotine and COHb levels of the two groups
indicating that their smoke intake was similar despite large di&rences in the yields
of their cigarettes [4, 51. It appears, thereiore, that those smokers who have
'.*bimm Ueic, New CIat Ho.petal, Leedoa SEi4
' Asreuhetic >lesumb Laboesoo.y, si. s.rtLoiomew9 Mospiral, r..de. Ee,.
C
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
146 Rursell, Sietton, I~, Fryerabtrid -and Vesey
themselves chosen to smoke a low-tar low-nicotine brand ('natural switching') alter
their smoking pattern and in so doing compensate almost completely for the reduced
yields of their cigarettes.
The other approach used to study compensation has been by experimental
switching. With this method smokers are required by the conditions of the study to
switch from their usual brand. In contrast to natural switching, the experimental
switching studies have shown that compensation though significant is on average
only partial (about 50 per cent) and that blood nicotine and COHb levels are lower
after switching, albeit proportionately less than the reduction in yields [6-9]. The
experimental switching studies have all been short-term, two weeks or less. It is not
clear whether this is the reason for the discrepancy. Would the subjects in the
experimental switching studies, who compensated only partially in the short-term,
have compensated fully if the studies had been prolonged? This important question
is unfortunately not answered by two longer-term studies of mouth-level nicotine
intake (based on butt analysis) [10, 111. Aside from their contradictory findings,
mouth-level intake does not reflect the depth of inhalation and 'u a poor index of
blood nicotine and COHb levels [ 12].
In this report we present the changes in blood nicotine, cotinine, COHb and
thiocyanate (SCN ) levels of twelve smokers before and after switching to a low-tar,
low-nicotine cigarette for ten weeks. We were particularly interested to explore the
extent to which these smokers responded to this relatively long-term switch by
inhaling more deeply to compensate for the lower yields or by adapting to a lower
intake of smoke constituents.
Subjects and Methods
The subjects were recruited by advertising in local newspapers for.rolunteen to take
part in a study of less harmful cigarettes. 66 subjects attended on the first occasion
and 29 completed the three attendances required for collection of baseline data (see
below ). These 29 were then randomly assigned to switch to one of two types of 'safer'
cigarette for ten weeks. One group (N=15) were given a specially designed low-tar
medium-nicotine cigarette. The other group (N=14) were given a conventional
low-tar low-nicotine cigarette. This report is confined to those who were given the
low-tar low-nicotine cigarette. Since we are concerned here with responses to
switching to lower yield cigarettes, two of the subjects who were already smoking
low-nicotine cigarettes (0.7 and 0.9 mg ) have been excluded leaving a final sample of
12 subjects (8 women and 4 men ). Details of the subjects and their usual brands of
cigarette are shown in Table 1.
The subjects attended on nine occasions over a period of 12 weeks. They
attended in the afternoon or evening of a weekday, the time of attendance of
individual subjects being similar (within 30 min:) on all occasions. On occasions I
and 3 the subjects had been smoking their usual brand in their usual way. On
occasion 2 they had been smoking a popular commercial brand of middle-tar,
medium-nicotine King Size (84 mm) filter cigarette (Tar 19.0 mg, Nicotine 1.3 mg
and CO 20 mg) throughout the day. On subsequent occasions they had been
smoking the experimental low-tar, low-nicotine cigarette which was also King Size
(84 mm) and filter tipped (Tar 10.9 mg, Niootine 0.7 mg, CO 12.9 mg). There were
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Iang-Tirm Suritdting to Low-Tar Loro-Niuotint Cigarcttcs
Table I Details oC the 12 subjects and their usual smoking habits
147
Usual 'Usual Brand Standard yields (mg)
Sex & Age
of subjects Consumption
(cigs/day)
Site
Length
(mm )
Tar
Nicotine
CO
1. F 35 35 SasaIl 65 19 1.3 15.7
2. F 56 50 Regular 69 19 1.5 19.0
3. M 39 30 Small 66 16 1.1 13.3
4. F 50 40 King Size 84 18 1.3 18.8
5. Xi 41 35 Small 66 19 1.2 18.3
6. F 31 30 Small 66 19 1.2 18.3
7. tii 46 30 King Size 84 18 1.5 18.3
8. F 43 60 Long Size 79 12 1.3 11.5
9. hi 27 40 King Size 84 18 1.5 18.3
10. F 26 20 King Size 83 18 1.4 18.0
11. F 27 40 King Size 84 18 1.5 18.3
12. F 26 45 King Size 84 15 1.1 15.6
Mean 37.3 37.9 76.2 17.4 1.33 17.0
SD 10.2 10.5 8.8 2.1 15 2.4
' AJD cigarsttes were 6ltertipped.
about 3 weeks, on average, between occasions I and 2, and about 7 weeks between
occasions 2 and 3. After switching to the experimental low-tar low-nicotine cigarette,
subjects attended after 2 days and then at 2-week intervals for 10 weeks.
The experimental cigarettes were supplied by British American Tobacco
Company (BAT). They were in plain white packs of twenty, labelled with a code
number only, with no indication that they were low-tar low-nicotine cigarettes. To
provide some, but not too much, encouragement to participate in the study the
experimental cigarettes were supplied at roughly 30 per cent discount on the cost of
the subjects' usual brands. Travel expenses were also paid but there were no other
financial inducements.
Prior to each attendance subjecu kept a record of their cigarette consumption
that day up to the time of arrival as well as.a sample of their cigarette butu. On
arrival they smoked a cigarette on a puff analyser (13). On some, but not all,
occasions a venous blood sample was taken two minutes after the cigarette was
completed. The'blood samples were taken on the first three base-line occasions and
then at 2 days, 8 weeks and 10 weeks after switching to the experimental low-tar,
low-nicotine cigarette. They were analysed br COHb using an IL 182 CO-oximeter
[ 141 and plasma nicotine was measured by gas chromatograph j 15). The nicotine
content of the cigarette butts was measured by BAT. Subjective ratings of the
acceptability of the cigarettes were taken on all occasions. These included ratings of
satisfaction, taste, ease of puffing, missing usual brand, diSficulty keeping on the
experimental cigarette and perceived ability to change permanently to it.
The main statistical analyses were orthogonal single degree of fseedom
comparisons (16), firstly between the usual brand and the control middle-tar brand
and secondly between the usual brand and the low-tar low-nicotine cigarette. Other
comparisons were made using t-tests.
0
i

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
148 Russcll, Sytto>'t, Iyer, FeyerebeAd axd Vesey
Resulta
The various measures of smoke exposure (cigarette consumption, mouth-level
intake and blood measures ) of the 12 subjects are shown in Table 2 and Figure 1. It
can be seen by the points in the figure and the SDs in Table 2 that there was wide
variation between individual subjects. The average levels, however, were very
similar on the two occasions they were tested when smoking their usual brands.
Likewise, after switching to the control middle-tar brand they were a2w similar, and
apart from the tendency to puff less nicotine from the control middle-tar brand than
from their usual brands (mouth-level intake 0.9 mg vs 1.14 mg, F-4.97, df 1/11,
p<.05 ), there were no significant changes in the various measures of smoke intake
after switching to the middle-tar brand. On switching to the low-tar low-nicotine
cigarette, however, there were substantial reductions in some of the measures of
exposure as described below.
Table 2 Cigarette consumption, mouth-level intake of nicotine and blood concentrations of vari-
ous smoke components of 12 stnokers when smoking their usual brands and after switching to a
middle tar brand br one day and a low-tar low-nicotine cigarette for up to ten weeks.
(Means and SDs ).
Middk
T Low-tar, Low-nicotine brand
Usual
Variable Brand ar
Brand Usual
Brand
2 days
8 weeks
10 weeks
Cigarette consumption 23.8 20.2 20.2 21.2 23.2 23.9
( 8.1) ( 7.2) ( 7.0) ( 7.0) (13.4) ( 8.9)
Mouth-kvel nicotine intake
(mg/cig)
Smoked in laboratory
1.61
-
-
0.83'
-
0.74'
( .48) ( .24) ( .17)
Smoked naturally 1.14 0.90' - 0.64` - 0.60=
( .36) ( .23) ( .22) ( .15)
Plasma nicotine (ng/ml) 32.4 35.2 33.2 20.8' 22.T 22.8'
(12.3) (15.4) (14.3) ( 8.4) ( 7.7) ( 6.5)
Plasma eotinine (ns/ml ) 350 - - - - 246'
(140) (134)
COHb (!i ) 7.4 8.0 7.0 6.9 7.6 7.8
( 2.0) ( 2.3) ( 2.4) ( 1.9) ( 1.7) ( 1.6)
Piaasta thioeyaaate (t~enol/1) 150 156 140 142 155 167
(36) (35) (S1) (32) (36) (75)
Note: The eeder of the oolttttunt refleets the atkr of switc4iug te vatiour braads (iee tsn ).
Ci4uette eoesump-
doe refers eot to a fnll day's ooawmptioa but a the stanber of ciptetta smoted up w the ti[ne of
attendance.
>tlout6-kvel istake is aa escimate of tbe dou of aieotiee pWSed iato the nouth. It was calculated
fran the butt
aicatine metent and the GIser edieieaey. Data aa plawaa catieine and .oab-ievd intalte were
incomplete (.re
oe:t ).o tbttt tye valnes for sval beaed are the eeana ot tLe two ." brand oecasioos aad the values
ibown at
10 weeks oe the low tar Ixaed aee the taeam for i and 10.reeb. The steses tor'tuma cacmiae tepeseet
onl)
8 ef t6e 12 snbjeet: as do thoa for tie nouthlevet iuakr daiootine 2 days alter switeA* to the
low4ar.
bw-aieatieie beand. The kvelt otwtistiea! siBaiCicasee ttkr a mmpariteaawith tLr dsual brand; `<A5,'
p<.0I .'
p<.001.
I

i
Long-Term Swikleing to Low-Tar Lom-Nicotine Cigarettes 149
~
~ 60
50
40
30
20
1
t
1
1
~
~
10
8
6
4
Plasma Nicotine (ng/ml)
10 U1 --1
Brand
COHb (%)
Low Tar
Brand
Plasma Cotinine (ng/ml)
600
500
400
300
200
1001 1
Usual
Brand
12 r 2.0 r
.
_
~
LJ_
Z Usual
Brand
-
Low Tsr
Brs+x!
..
Mouth-level Nicotine
Intake (mg/cig)
.
1.6
1.2
0.8
_
_
..
0.4
0
i
Low Tar
Brand
i
Uswl Low TK
Brand &"
Fipre 1 Messarm af anoke intake wben tmokiag trwl braad: and after nvitc3tisK to a low-car
low-aicotiae cigarette br 8-10 weehs. EAcb paiat is the meaa oi cwo oaasio~n.
~

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
150 Russell, Sutton, lya, Feyerabrnd and Vesey
Cigarette con,rioreption. There was no significant change in cigarette consummptic>n on
witching frotnthe usual brands tfl the low-tar cigarette !F=0.45, df 1/ 11, NS, Table
2).
Mouth-level nicotine iatahe. This is an estimate of the amount ofnicotine puffed into the
smoker's mouth and is calculated from the butt nicotine content and the efficiency of
the filter. When smoking their usual brands under natural conditions outside the
laboratory the subjects puffed an average of only 1.14 mg nicotine per cigarette
(Table 2). This is 14.3 % less than the 1.33 mg average of the machine-smoked
nicotine yields, but this difference is not significant (t=1.8, df 11). the month-kwel
4nske of nicotine was significantly ~reduced after switching to the l~ow-tar
low-nicotine cigarette when smoking in the laboratory and under natural conditions
(Table 2, Fig. 1). The amount of nicotine the smokers pu$'ed from the low-tar
low-nicotine cigarette was similar to its standard machine-smoked yield of 0.7 mg
nicotine. The amounts ofnicotine puffed from the cigarettes were consistently higher
when smoked in the laboratory compared to natural conditions, the increases
averaging 31.3 % for the three comparisons shown in Table 2. There was a
systematic decline in this di8'erence as subjects became more fimiliar with the
laboratory procedure, the laboratory smoked level being 41 % higher for the usual
brand (p<.001), 30 % higher for the low-tar cigarette at two days (p<.025 ) and 23 %
higher for the low-tar cigarette at 8-10 weeks (p<.05 ).
Plasma sicotnu. The average plasma nicotine concentrations on the two occasions of
smoking the usual brands were very similar (t=0.2, Table 2). They were also fairly
consistent within subjects (r=.88). The average level was also similar when smoking
the control middle-tar cigarette which had a similar nicotine yield to the average of
the usual brands (1.3 vs 1.33 mg). On switching to the bw-tar low-atcotine
cigirette, plasma nicotine kvels' were reduced subniatiilly (F=22.7, df 1/11,
p<.001). There was no significant difference between the short-term reduction of
37 % at 2 days and the longer term reduction of 30 % at 8 and 10 weeks (F=2.3, df
1/11, NS). These reductions were, however, less than the 47% reduction in
machine-smoked yields from 1.33 mg to 0.7 mg nicotine (Figure 2).
Plesnia cotiaiu. As a main metabolite of nicotine, plasma cotinine provides a useful
check on the plasma nicotine data. Another advantage is its longer half-life in
plasma. Whereas plasma nicotine levels arr determined predominantly by nicotine
intake from the cigarette smoked just before blood sampling, plasma cotinine reflects
the nicotine intake from all the cigarettes smoked during the day and to some extent
the preceding day. It is only recently that we have developed this measure so that it
was done only in tbose samples that had sufficient plasma left over for storage. The
aimited data fi+em eight ofthe subjects do, however, support the pluasa niootine data
in showing an idenatic:l and aatisticalty o6ni5unt redtsctioo d301i at 8 and 10
weeeits a&er rvrkehing so the bw-mar low4iootme ciguetoe (t=6.3, df 7, p<.001).
COHb. There were no significant changes or trends in COHb on switching to the
control middle-tar cigarette or to the low-tar low-nicotine cigarette despite the fact
that the machine-smoked CO yield of the latter was 24 % bwer than the mean CO
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
Loag-Terrn Switeking to Low-Tar Low-Nicotine Cigarettes 151
yield of the subjects' usual brands. There was some consistency within subjects on
the two occasions they were smoking their usual brands (r=.73).
Plasma thiocyanate. Tlie very long half-life in plasma (2 weeks) makes this measure
inappropriate,for assessing short-term changes in smoking. There was a fair degree
ofconsistency within subjects for the two occasions on their usual cigarettes (r=.76),
but there were no significant changes after switching to low-tar low-nicotine
cigarettes. Direct comparison of the means of the two occasions on the usual brands
with the means of the 8 and 10 week values on the low-tar low-nicotine cigarette
showed that they were not significantly different (145 vs 161 umol/l, F=1.1, dfl / 10,
NS).
Talbk 3 Measures of pu6irtg behaviour when smoking usual brands and after switching to a
middle tar brand for 1 day and a low-ur low-nicotine brand for up to 10 weeks. (Means )
Middle Low-tar, bw-nieotitte brand
Variable Usual
Brand tar
Brand
2 days
8 weeks
10 weeks
Butt kttgth (mm) 27.8 30.7' 28.0 28.5 27.7
Number of pufTs 14.7 15.3' 14.6 16.8' 17.3'
Inter-puff interval (sec) 25.6 28.4 28.3 25.4 26.2
Total time to smoke cig. (min) 5.4 6.2 6.3 6.2 6.4
Puff duration (sec) 2.3 2.3 2.5' 2.3 2.3
PuBpre:sure (crnWG per sec) 28.0 34.2` 30.7' 27.8 28.0
Puff volume (ml) 39.8 38.8 38.5 36.7 35.8
Total volume puffed (tn1) 547 569 5,49 573 579
Note: Due to missuta data tlr values for the tusual bnnd an the meatu of the two oeeations oa whieb
uswl
brands were tested, and the values for the asiddk-tar brand are the means of only e of the 12
subjects. The
levels of statistical tisnificance rekr to compari.m with the usual brsad; ' p<.05,' p<.Ol.
Pud-sag Behaniour. Although the subjects were dearly puffing their usual brands
faster than the standard machine-smoked rate of one 35 ml puff of 2 sec.
duration per min, there were no significsnt changes in puff volume, oeesl volume
puffed, puff rate and time taken to :moice a cigarette after switching to the eontrol
middle-tar brand and the low-tar lowvdootiae cigarette (Table 3). Subjects left
longer butts when smoking the control middle-tar brand and tbere were sig-
nificant increases in puff pressure and the number of puffa. After switching to the
low-tar low-nicotine cigarette, pu>g' volume was maintained in the short term (2
days) by increasing puff pressure and duration, whereas in the longer term the
number of pu$s was increased. These changes in puffing behaviour could have
been due to differences in draw resistances of tbe cigarettes but we had no data
on the draw resistances of the usual brands. Wbat is 'siaportaat, bowever, is the
Lck d'signifiaat ebana U puff voicme aod soul volume puSed after switching
to the low-tar bw-a>~oocioe titsrewe-
Aasptability. Subjects rated the control middle-tar beand as less good to taste and
less easy to puff than their usual brand (Table 4). The bw-tar law-oiootine
I

I
I
I
I
I
I
I
I
152 Ruuell, Sutton, I,yer, Fryercbend and Vesey
TaMe 4 Subjective ratings of acceptability of usual brand, a control middle tar brand and a
bw-tar iow-aicotine brand. (Means of 12 subjects)
Middle Low-tsr low-nicotine brand
Usual tar Usual
Variable Brand Brand Brand 2 days 8 weeks 10 weeks
Satisfaction (100=very) 86 62 79 71 81 82
Taste (100-very good ) 82 68' 83 72 76 73
Too strong (100-much) 25 32 26 25 13 18
Too weak (100-much) 13 24 22 34' 2T 26'
Ease of puffing (100=hard) 17 30' 14 33' 19 22
DitLculry keeping on test
cig. (100=very ) - 10 - 10 5 5
Missed usual brand (100-a lot) - 17 - 26 11 11
Cou1d stay on test cigarette
permanently - 1.75 - 1.67 1.0 1.0
for 8 weeks - 1.5 - 1.5 1.0 1.0
Number of subjects who
prefetxd test cigarette - 1 - 2 10 l0
Definitely - 1, probably - 2, pnobably aot - 3, definitely not - 4.
The kvelt of statistial sjnifinnee refer to coatpariaons with the usual brand;' pt.05, i p<.p1.
eigarette was rated as a little too weak but it was compared very favourabty with
~ the control middle-tar brand in the short tam, and in the long term is rated as
well as the usual brand apart from being too weak. Indeed, in the long term it
was sctually prekrred to the usual brand and all twelve subjects thought that they
. eould cbange to it permanently.
,i Degree of compeasad'oa. Oa awitehing to the bw-tu lowrnicadne ei6arette the
seducti+oa in nauth-ievel nicotine intake, plasma nicotine and cotinine were (as
~ mentioned above and shown in Fig. I and Table 2) substantial, consisteat and
.tatistically si6ni6cant The reductions in plasma nicotine and cotinine were,
however, proportionally less than the reduction in standard machine-smoked nic-
' otine deliveries indicating that the subjects made some compensatory increase in
/!!! inhalation. Some idea of the degree of compensation is gained by the amount that
the observed values were raised above the levels that would be expected if there
was no compensatory change. This is shown in Figure 2:~it caa be aeea that there
a wu uo.ownpenatioa fn terms ef mouth-leslel intake, but piauna aiootine and
, .ootinisne values showed partial oompenation in the amo®t of ntoatine inhoed.
In contrast, the COHb data showed complete compensation, the levels on the
,~ low-tar low-nicotine cigarette being similar to those on the usual brands.
I Expressing compensation in perantage terms (Table 5) makes it possible to
compare the degree of compensation shown by diSerent measures of smoke
intake. Other calculations are shown for the compensatory increase in smoke
' intake and the theoretical increase that would be necessary, given the reduction
in machine-smoked deliveries, to achieve complete campensation. This latter
measure is less i'or COHb (31.6 %) than i'or nicotine and its metabolite cotinine
(88.7 %) because the reduction in machine-anoked CO yield of the low-tar low- ~
~ nicotine cigarette was less than the reduction in nicotine yield. The compensatory ~
~a.
©
~
00

I
I
I
I
I
1
I
I
I
I
I
I
I
I
I
I
Loag-Tenn Switching to Low-Tar Low-Nicotine Cigarctka
153
Tsjbk 5 Calculations br compensatory changes in smoking behaviour after changing to bw-tu,
low-nicotine cigarettes for 8-10 weeks. (Means of 12 subjects). The machine-smoked ratio br ootinine
is based on the nicotine yield.
Mouth-kvd
nicotine intake Plasma
nicotine Plasma
eotinine
COHb
AlacAruvrntaErd yu/dr
Usual cigarette
1.33 mg
1.33 mg
1.33 mg
17.0 mg
Low-tar cigarette 0.7 mg 0.7 mg 0.7 mg 12.9 mg
LT/ustul (a) .53 .53 .53 .76
Memmed istlmEe
On usual cigarette 1.14 mg
32.8 nglml
350 ng/ml
7.2 %
On Low tar cigarette 0.60 mg 22.8 ng/ml 246 ng/ml 7.7 %
LT/usual (b) .53 .70 .70 1.07
Co+espt+tutory isk-reau
a Moke raemtr (%)
b
-IJx 100 (c) 0.0%
a
Issrreau i+r nwo,Er ottate
aaruory for cmplete
eenrpeacorron
1- a x 100 (d) 887%
~ ]
2.1%
8.7%
2.1%
8.7%
0.8%
1.6%
a
lktrer of c.wtpruattan (%)
d x 100 0.0 %
36.1 %
36.1 %
130 %
Comparisons of the usual and IoM tar, low-nicotirx brands are based on the mearu of the two
oeeasions on the
usual brand and the means of the attendances aher 8weeks and 10 weeks on the fowaar, bw-nicotiee
eigarette.
The cotinine values are the means of only 8 of the 12 subjeets (see te:t).
increase in smoke intake was nil at mouth-level, but the blood measures show the
increase in inhalation to have been somewhere between 32.1 % and 40.8 %. The
cyanide yields of the usual brands of cigarette were not available so that the
plasma thiocyanate levels could not be used to estimate the corresponding measures
of compensation.
Estimatcs of rcduction as tar attake. Tar intake cannot be measured directly. How-
ever, it is possible to estimate di>8'ertaces in tar intake Erom different brands of
cigarette by using blood levels of an appropriate marker and relating these to the
ratio of the machine-smoked yields of tar and the marker to give a tar intake
index for comparison between brands. Such an estimate assumes that the ratios
for human smoking are directly proportional to the machine-smoked ratios and
that tar deposition is directly proportional to absorption of the marker. Using
nicotine as the marker, for example, a tar intake index for a particular cigarette
can be obtained as follows:
Tar intake index = plasma nicotine x Tar/Nicotine ratio
With this formula the mean tar intake index for the twelve subjects on their
usual brand was 32.8 x 13.1 - 430 and on the bw-tar low-nicotine brand (after
8-1Q weeks) it was 22.8 X 15.6 - 356, i.e. a reduction of 17.2%. Using similar
calculations the reduction based on piasma cotinine was 16.3 % and that based
I

I
I
I
I
I
I
I
I
I
154 Russell, Sutton, Iw, Ft,yerabend and Vcsry
40
COMpENSATION AT 2 DAYS APD 8-10 WEEKS
Plasma Nkotine (npJml) PlesmsCotnine (npJml)
, 400,
ao-
20
10,
0
. .
7
a0o-~
200
100
0
tJkr! LT lT LWAI lT
2days i-10 -10
M.ks .rphs
COHb (y.) lAOtlth-IeMN NlCditE Irrtihe,
rt6tur61 ttnoKrp (mpkp)
:-;
1.Z ^
4.
~-i r-
!~ 6...-1
081
0-41~
'
I
I
I
I
I
I
I
0 ` . 0 LUsuM LT lT Urrl lT lT
2days i-10 ld"s i-10
.w"s wefts
F#;ue 2 Compensation at 2 days and 8-10 weeks after changing from usual brands to a low-tar
bwqiooti»e (LT) cigarette (meaas of 12 su*cts, 8 in the ease of cotinine). The shaded areas tboa
the amount of contpen:atioa and repreieat the diBereate between the obarved leveh (npper point )
and 'expected' levels (lower poiat). Tbe 'excepted' leveh are tbou predicted 5om the tedwtiest in
machine-anoked yield assuming that tltere was so e5atp in tutyokiai patteta. The broken lirrcs
tspee.eat the kveit of tbe ttaadaze! m.etiioeytnoked yidds. SqaiBcsna of ob.erved-espected dif-
fiereaca; p<Al, Pt.001.
on COHb (after :ubtractiag 1.0% br background level in non-smokers) it was
11%.
If these estimates an eorrect in showing a reduction in tar intake after switch-
ing to the low-tar low-nicotine cigarettes this would indicate that, as with nic-
otine, titruioa of tar intake was also incompkte. Using calculations shown in
Tabk 5, the estimated degree of compensation of tar intake was 54% using nic-
atine and cotinine as markers and 68% using CO as the marker.
,
I
